The Valley Desk

NCT00348140 · Interventional trial

Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease

Overall registry status Completed

Phase 3

Conditions Alzheimer's Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov